KALA - Kala Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts3234
Avg. Estimate-0.6-0.56-2.73-2.17
Low Estimate-0.68-0.64-2.81-2.54
High Estimate-0.46-0.48-2.57-1.62
Year Ago EPS-0.76-0.75-2.49-2.73
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts5356
Avg. Estimate3.11M4.63M8.05M32.16M
Low Estimate2.5M3.4M7.4M17.16M
High Estimate4.27M5.5M9.2M46M
Year Ago SalesN/A1.1MN/A8.05M
Sales Growth (year/est)N/A320.90%N/A299.50%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.52-0.75-0.73-0.67
EPS Actual-0.76-0.75-0.7-0.68
Difference-0.2400.03-0.01
Surprise %-46.20%0.00%4.10%-1.50%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.6-0.56-2.73-2.17
7 Days Ago-0.6-0.56-2.73-2.17
30 Days Ago-0.65-0.64-2.75-2.12
60 Days Ago-0.65-0.64-2.75-2.12
90 Days Ago-0.66-0.64-2.78-2.19
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 Days1121
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1N/A1N/A
Growth EstimatesKALAIndustrySectorS&P 500
Current Qtr.21.10%N/AN/A0.01
Next Qtr.25.30%N/AN/A0.06
Current Year-9.60%N/AN/A-0.03
Next Year20.50%N/AN/A0.14
Next 5 Years (per annum)31.70%N/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A